BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24767518)

  • 1. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
    Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
    J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
    Colagiuri B
    Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing allocation concealment and blinding in randomised controlled trials: why bother?
    Schulz KF
    Evid Based Nurs; 2001 Jan; 4(1):4-6. PubMed ID: 11707879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical aspects of randomization and blinding in randomized clinical trials.
    Bridgman S; Engebretsen L; Dainty K; Kirkley A; Maffulli N;
    Arthroscopy; 2003 Nov; 19(9):1000-6. PubMed ID: 14608321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 12. Deliberate ignorance: a systematic review of blinding in nursing clinical trials.
    Polit DF; Gillespie BM; Griffin R
    Nurs Res; 2011; 60(1):9-16. PubMed ID: 21127453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinding in randomized controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study.
    Probst P; Grummich K; Heger P; Zaschke S; Knebel P; Ulrich A; Büchler MW; Diener MK
    Syst Rev; 2016 Mar; 5():48. PubMed ID: 27012940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEPERROR: Risks of systematic errors in drug and non-drug randomized clinical trials assessing intervention effects in patients with unipolar depression.
    Krogh J; Hjorthøj CR; Jakobsen JC; Lindschou J; Kessing LV; Nordentoft M; Gluud C
    J Affect Disord; 2015 Jul; 179():121-7. PubMed ID: 25863907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
    Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
    Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 18. Discrepancy between published report and actual conduct of randomized clinical trials.
    Hill CL; LaValley MP; Felson DT
    J Clin Epidemiol; 2002 Aug; 55(8):783-6. PubMed ID: 12384192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study.
    Herbison P; Hay-Smith J; Gillespie WJ
    J Clin Epidemiol; 2011 Oct; 64(10):1070-5. PubMed ID: 21474279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.
    Baethge C; Assall OP; Baldessarini RJ
    Psychother Psychosom; 2013; 82(3):152-60. PubMed ID: 23548796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.